Navigation Links
Genetic Testing for All: QTrait Offers Industry's Least Expensive, Most Secure DNA Tests With TRUSTe Certification

SEATTLE, April 24 /PRNewswire/ -- iGenix, Inc, today launched QTrait, a personal online genetics testing service with prices beginning as low as $99 per DNA test. iGenix co-founder and chief scientist Tera Eerkes, Ph.D. developed QTrait to create affordable DNA testing for the general public, while providing the most secure privacy procedures in the genetics industry. QTrait tests have received certification from TRUSTe, a leading consumer privacy group that helps consumers and businesses identify trustworthy online organizations.

QTrait test categories include: 1) Health and Longevity; 2) Addictive Tendencies; 3) Nutrition and Allergies; 4) Pregnancy and Childbirth; 5) Sleep and the Senses; and 6) Performance. Tests range from $99 for one test, up to $749 for 30 or more tests.

"QTrait proves that secure DNA testing isn't just for the wealthy," said Eerkes, who has a doctorate in Genome Sciences from the University of Washington. "Anyone should be able to learn about their genetic make-up, and have the right to keep that information 100 percent private."


Designed by a team of scientists and physicians, QTrait tests are highly accurate. They differ from tests that evaluate disease detection or prevention. QTrait evaluates the genetic component of existing disorders or conditions that can be improved through detection and behavior modification, like allergies. QTrait also provides assessments that can improve lifestyles, such as insights on aptitudes for memory and retention.


Many people are worried that employers might discover their personal genetic information and use it to discriminate against them, Some are concerned that insurance companies might deny coverage based on unfavorable results. To protect privacy, many consumers choose to pay out-of-pocket for extremely expensive DNA tests that might normally be covered under insurance. Prior to QTrait, standard industry tests ranged from $175 per test up to $350,000 to map an individual's entire genome. To help make this type of information more accessible, QTrait offers the market's least expensive pricing, starting at $99.


People are unaware that many providers of DNA tests have contractual clauses that allow them to sell or release their customers' information to third parties. This raises many ethical concerns as third party organizations can mine DNA data for health, marketing or identity information. A person's DNA never changes. Since genetic information is a unique "fingerprint", once a person is distinguished by genetic information, that person is always potentially identifiable.

Unlike other genetic testing companies, QTrait guarantees its clients' privacy. QTrait does not share genetic information with outside parties, except under court order. After QTrait customers receive their results, they can at anytime delete the information from the QTrait database; thereby, guaranteeing the data will not be available to third parties or unauthorized individuals.

Eerkes explained, "With QTrait, people don't need to worry that we'll release their genetic information to an insurance or pharmaceutical company. Our customers feel safe knowing they have complete control over their DNA information because they can delete their test results whenever they want."


To protect customers' privacy, QTrait encrypts genetic information in the company's databases. Names and account information are anonymized and kept separate from test results. QTrait staff and employees are limited in their access to both test results and clients' personal information. The company also encrypts genetic information when it is transferred through the network into its database.


Many personal genetics companies bundle their services and force customers to receive results that they didn't request. Some individuals are concerned that DNA tests will reveal genetic predispositions that they would rather not be alerted to or believe they can't change. Still, they may wish to seek evaluations for other conditions or aptitudes. With the QTrait system, individuals only receive information that they want.

Other individuals feel that knowledge is power, and identifying their predispositions can help them make changes to improve their health and quality of life. QTrait is a solution for both sets of customers. It allows each to choose the tests that they want. With QTrait people learn as much, or as little, as they want to know about their genetic make-up.


QTrait has more than 40 genetic tests in categories that include: 1) Health and Longevity; 2) Addictive Tendencies; 3) Nutrition and Allergies; 4) Pregnancy and Childbirth; 5) Sleep and the Senses; and 6) Performance. QTrait genetic tests can help:
-- Adults and children identify genes that indicate conditions and

allergies such as: asthma, lactose intolerance, eczema, and gluten


-- Parents evaluate their child's potential susceptibility to smoking,

alcohol or drug addictions.

-- Women determine prenatal risks such as preeclampsia or preterm birth.

-- Athletes evaluate performance genes that process oxygen levels in

blood; and aptitude for endurance versus power sport training.

-- Individuals assess aptitudes for memory and retention.


QTrait makes genetic testing easy. Customers go to, where they select and purchase only the genetic tests that they want. QTrait will then ship a personal saliva test kit. The customer will provide a saliva sample and mail the kit back to QTrait. Within eight weeks of receiving the test kit, QTrait will process the results. When the results are ready, QTrait will email the customer a link to their information. Customers must use a unique and secured pass key and pass phrase to sign in to see their results.


iGenix is a privately held company that is pioneering personal genetics by using technological innovations designed to lower DNA testing costs. Chief executive officer and chief scientist Tera Eerkes, Ph.D. and Dr. Carl Newman founded the company in 2007 to provide the most secure, conscientious and affordable genetic testing to the public. Eerkes received her doctorate in Genome Sciences from the University of Washington and conducted scientific research in genetics and genomics at the Fred Hutchinson Cancer Research Center. Before co- founding iGenix, Dr. Carl Newman worked more than 30 years as a practicing clinical physician. For more information about iGenix and QTrait, visit:

SOURCE iGenix, Inc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
2. Response Genetics Reports Second Quarter 2007 Financial Results
3. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
4. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
5. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
6. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
7. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
8. Interleukin Genetics Announces Management and Board Appointments
9. Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences
10. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
11. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider of ... , today announced that the company has set a new quarterly ... quarter on quarter growth posted for Q3 of 2014 to Q3 ... Mexico , with the establishment of an ... --> United Kingdom and ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
(Date:11/24/2015)... ... 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions for ... Aregger to serve as Chief Operating Officer. , Having joined InSphero in ... and was promoted to Head of InSphero Diagnostics in 2014. There she ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
(Date:10/29/2015)... Oct. 29, 2015 Daon, a global leader ... has released a new version of its IdentityX ... North America have already installed IdentityX ... includes a FIDO UAF certified server component ... to activate FIDO features. These customers include some of ...
Breaking Biology News(10 mins):